Neoadjuvant randomized trial of degarelix (Deg) +/- cyclophosphamide/GVAX (Cy/GVAX) in men with high-risk prostate cancer (PCa) undergoing radical prostatectomy (RP).

Antonarakis E. S., Zahurak M., Schaeffer E. M., Partin A. W., Ross A., Allaf M., ...More

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 35
• Doi Number: 10.1200/jco.2017.35.15_suppl.5077
• City: Illinois
• Country: United States Of America
• Süleyman Demirel University Affiliated: No